Lymphoma Steering Committee Roster
The Lymphoma Steering Committee (LYSC) addresses the design, prioritization, and evaluation of concepts for phase 2, 2/3, and 3 clinical trials in adult lymphoma. Committee activities help foster collaboration between groups and institutions engaged in conducting trials. The LYSC's membership comprises NCTN group representatives, NCI-funded consortia representatives, community oncologists, Specialized Programs of Research Excellence (SPORE) representatives, biostatisticians, patient advocates, subject matter experts, and NCI staff.
Co-chairs
Steve Ansell, M.D., Ph.D.
Mayo Clinic
Rochester, MN
Kristie A. Blum, M.D.
Emory University Winship Cancer Center
Atlanta, GA
Members
Tareq Al Baghdadi, M.D.
St. Joseph Mercy Hospital
Ypsilanti, MI
Richard F. Ambinder, M.D., Ph.D.
Johns Hopkins University
Baltimore, MD
Nancy Bartlett, M.D.
Washington University School of Medicine
St. Louis, MO
Timothy Fenske, MD
Medical College of Wisconsin
Milwaukee, WI
Christopher Flowers, M.D., M.S., FASCO
University of Texas MD Anderson Cancer Center
Houston, TX
Boris Freidlin, Ph.D.
National Cancer Institute
Bethesda, MD
Jonathan Friedberg, M.D., M.M.Sc.
University of Rochester Medical Center
Rochester, NY
Meghan Gutierrez, B.A.
Lymphoma Research Foundation
New York, NY
Tricia Hernandez, M.S.
Leukemia and Lymphoma Society
New York, NY
Alex Herrera, M.D.
Beckman Research Institute City of Hope Medical Center
Duarte, CA
Bradford S. Hoppe, M.D., M.P.H.
Mayo Clinic
Jacksonville, FL
Brad Kahl, M.D.
Washington University School of Medicine
St. Louis, MO
Lale Kostakoglu, M.D.
University of Virginia
Charlottesville, VA
John Kuruvilla, M.D., FRCP
University of Toronto Princess Margaret Cancer Centre
Toronto, ON, Canada
Michael LeBlanc, Ph.D.
Fred Hutchinson Cancer Research Center
Seattle, WA
John P. Leonard, M.D.
Weill Cornell Medical Center
New York, NY
Richard Little, M.D.
National Cancer Institute
Bethesda, MD
Peter Martin, M.D.
Weill Cornell Medical Center
New York, NY
Alison Moskowitz, M.D.
Memorial Sloan Kettering Cancer Center
New York, NY
Ryotaro Nakamura, M.D.
Beckman Research Institute City of Hope Medical Center
Duarte, CA
Chelsea C. Pinnix, M.D., Ph.D.
University of Texas MD Anderson Cancer Center
Houston, TX
Mei-Yin C. Polley, Ph.D.
University of Chicago
Chicago, IL
Carlos Almeida Ramos, M.D.
Baylor College of Medicine
Houston, TX
Mark Roschewski, M.D.
National Cancer Institute
Bethesda, MD
Kerry Savage, M.D.
University of British Columbia
Vancouver, BC, Canada
Laurie Sehn, M.D.
University of British Columbia
Vancouver, BC, Canada
Anurag K. Singh, M.D.
University of Kansas Medical Center
Westwood, KS
Sonali Smith, M.D.
The University of Chicago
Chicago, IL
NCI CCCT Program Director
Elena Schwartz, Ph.D.
elena.schwartz@nih.gov